Trial intelligence / Profile preview

Tiotropium vs. ICS in Children With Nonatopic Asthma

NCT04990167Phase 2Terminated

Sponsor
Nemours Children's Health
Start
Jan 2022
Primary completion
Oct 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tiotropium in asthma, sponsored by Nemours Children's Health. Started Jan 2022; status: terminated.

02

Drugs

tiotropium
03

Conditions

asthma

Beyond the preview

Go deeper on NCT04990167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04990167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call